Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
RES.BR Stock Summary
In the News
RES.BR Financial details
Company Rating
Strong Buy
Market Cap
0
Income
16.93M
Revenue
409.85M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
979
Optionable
No
Shortable
Yes
Earnings
31 Aug 2020
P/E
18.04
Forward P/E
-
PEG
-6.91
P/S
-
P/B
2.53
P/C
-
P/FCF
-
Quick Ratio
0.1
Current Ratio
1.53
Debt / Equity
0.13
LT Debt / Equity
0.03
-
-
EPS (TTM)
8.4
EPS next Y
-
EPS next Q
-
EPS this Y
14.07%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
10.68%
Revenue last 5Y
5.58%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
8%
ROE
15%
ROC
0.18%
Gross Margin
24%
Oper. Margin
8%
Profit Margin
6%
Payout
23%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
234-234
52W High
0%
52W Low
0%
RSI
-
Rel Volume
0.12
Avg Volume
1.63K
Volume
201
Perf Week
0%
Perf Month
-
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
0.3936
-
-
Volatility
0%, 0%
Prev Close
0%
Price
234
Change
-
RES.BR Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 162.32 | 196.57 | 206.14 | 186.35 | 215 | |
Net income per share | 7.81 | 9.13 | 8.17 | 11.37 | 12.97 | |
Operating cash flow per share | 14.48 | 7.41 | 9.42 | 25.13 | 18.69 | |
Free cash flow per share | 4.4 | -10.08 | -4.69 | 16.16 | 7.15 | |
Cash per share | 13.59 | 5.39 | 5.06 | 6.05 | 5.6 | |
Book value per share | 60 | 67.94 | 73.98 | 79.24 | 92.6 | |
Tangible book value per share | 50.23 | 58.37 | 64.52 | 69.76 | 83.1 | |
Share holders equity per share | 60 | 67.94 | 73.98 | 79.24 | 92.6 | |
Interest debt per share | 18.52 | 21.98 | 30.53 | 17.13 | 12.3 | |
Market cap | 473.82M | 473.82M | 469.72M | 469.31M | 469.31M | |
Enterprise value | 481.94M | 505.45M | 518.64M | 490.39M | 482.52M | |
P/E ratio | 29.94 | 25.62 | 28.62 | 20.58 | 18.04 | |
Price to sales ratio | 1.44 | 1.19 | 1.14 | 1.26 | 1.09 | |
POCF ratio | 16.16 | 31.56 | 24.83 | 9.31 | 12.52 | |
PFCF ratio | 53.17 | -23.22 | -49.87 | 14.48 | 32.71 | |
P/B Ratio | 3.9 | 3.44 | 3.16 | 2.95 | 2.53 | |
PTB ratio | 3.9 | 3.44 | 3.16 | 2.95 | 2.53 | |
EV to sales | 1.47 | 1.27 | 1.25 | 1.31 | 1.12 | |
Enterprise value over EBITDA | 13.46 | 12.06 | 12.13 | 9.83 | 8.81 | |
EV to operating cash flow | 16.44 | 33.67 | 27.41 | 9.73 | 12.87 | |
EV to free cash flow | 54.08 | -24.77 | -55.06 | 15.13 | 33.63 | |
Earnings yield | 0.03 | 0.04 | 0.03 | 0.05 | 0.06 | |
Free cash flow yield | 0.02 | -0.04 | -0.02 | 0.07 | 0.03 | |
Debt to equity | 0.29 | 0.31 | 0.4 | 0.21 | 0.13 | |
Debt to assets | 0.15 | 0.15 | 0.21 | 0.12 | 0.08 | |
Net debt to EBITDA | 0.23 | 0.75 | 1.14 | 0.42 | 0.24 | |
Current ratio | 1.57 | 1.36 | 1.31 | 1.51 | 1.53 | |
Interest coverage | 10.41 | 12.92 | 11.02 | 26.65 | 39.67 | |
Income quality | 1.85 | 0.81 | 1.15 | 2.21 | 1.44 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.26 | 0.22 | 0.37 | 0.26 | 0.23 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.08 | 0.07 | 0.07 | 0.07 | 0.06 | |
Capex to operating cash flow | -0.7 | -2.36 | -1.5 | -0.36 | -0.62 | |
Capex to revenue | -0.06 | -0.09 | -0.07 | -0.05 | -0.05 | |
Capex to depreciation | -1.29 | -2.13 | -1.53 | -0.91 | -1.17 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 102.71 | 118.15 | 116.65 | 142.36 | 164.41 | |
ROIC | 0.11 | 0.11 | 0.09 | 0.12 | 0.13 | |
Return on tangible assets | 0.07 | 0.07 | 0.06 | 0.09 | 0.09 | |
Graham Net | -32.94 | -44.2 | -44.38 | -33.91 | -36.87 | |
Working capital | 48.87M | 39.86M | 33.85M | 46.54M | 60.13M | |
Tangible asset value | 101.7M | 118.19M | 129.52M | 139.92M | 166.67M | |
Net current asset value | 12.58M | 9.52M | 8.93M | 25.89M | 46.63M | |
Invested capital | 0.29 | 0.31 | 0.4 | 0.21 | 0.13 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 53.34M | 66.05M | 57.94M | 45.71M | 63.31M | |
Average inventory | 53.79M | 67.46M | 73.04M | 64.92M | 73.46M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 87.16 | 82.94 | 50.17 | 61.79 | 89.03 | |
Days of inventory on hand | 79.64 | 92.42 | 74.8 | 83.54 | 93.45 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 4.19 | 4.4 | 7.28 | 5.91 | 4.1 | |
Inventory turnover | 4.58 | 3.95 | 4.88 | 4.37 | 3.91 | |
ROE | 0.13 | 0.13 | 0.11 | 0.14 | 0.14 | |
Capex per share | -10.08 | -17.49 | -14.12 | -8.97 | -11.54 |
Quarterly Fundamentals Overview
Last date of statement is 2021-12-31 for Q4
Metric | History | 2019-12-31 | 2020-06-30 | 2020-12-31 | 2021-06-30 | 2021-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | 48.92M | 33.5M | 21.08M | 23.89M | 13.21M | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.4 | 0.32 | 0.21 | 0.22 | 0.13 | |
Debt to assets | 0.21 | 0.17 | 0.12 | 0.12 | 0.08 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 1.31 | 1.32 | 1.51 | 1.48 | 1.53 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.07 | 0.07 | 0.07 | 0.06 | 0.06 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 33.85M | 36.62M | 46.54M | 53.25M | 60.13M | |
Tangible asset value | 129.52M | 132.72M | 139.92M | 148.27M | 166.67M | |
Net current asset value | 8.93M | 12.86M | 25.89M | 33.92M | 46.63M | |
Invested capital | 0.4 | 0.32 | 0.21 | 0.22 | 0.13 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
RES.BR Frequently Asked Questions
What is Resilux NV stock symbol ?
Resilux NV is a BE stock , located in Wetteren of Oost-vlaanderen and trading under the symbol RES.BR
What is Resilux NV stock quote today ?
Resilux NV stock price is $234 today.
Is Resilux NV stock public?
Yes, Resilux NV is a publicly traded company.